Arterial pressure, left ventricular mass, and aldosterone in essential hypertension

A H El-Gharbawy1, V S Nadig, J M Kotchen

  • 1Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA.

Insights

Aldosterone is linked to higher blood pressure and heart size in obese Black Americans with hypertension. These effects were less pronounced in obese White French Canadians, suggesting a role for aldosterone in hypertension disparities.

Area of Science:

  • Cardiology
  • Nephrology
  • Hypertension Research

Background:

  • Essential hypertension exhibits significant ethnic and racial variations.
  • Aldosterone plays a key role in regulating blood pressure and electrolyte balance.
  • Obesity is a known risk factor for hypertension and cardiovascular complications.

Purpose of the Study:

  • To investigate the relationship between aldosterone levels, blood pressure, and left ventricular size in Black American and White French Canadian patients with essential hypertension.
  • To explore potential differences in these relationships between the two ethnic groups, particularly in the context of obesity.

Main Methods:

  • Cross-sectional study involving 109 Black American and 73 White French Canadian hypertensive patients.
  • Measurements included 24-hour ambulatory blood pressure monitoring, plasma renin activity, plasma aldosterone levels, and echocardiography.
  • Patients were studied off antihypertensive medications.

Main Results:

  • Black Americans exhibited higher BMI, blood pressure, left ventricular mass index, and wall thickness compared to French Canadians.
  • Black Americans had attenuated nocturnal blood pressure dipping and lower serum potassium.
  • Plasma aldosterone correlated with nighttime blood pressure and cardiac mass in obese Black Americans, and with nighttime blood pressure in obese French Canadians.

Conclusions:

  • Aldosterone may contribute to elevated blood pressure and left ventricular hypertrophy in obese Black Americans with essential hypertension.
  • Aldosterone's association with blood pressure was also observed in obese French Canadians, but not consistently with cardiac mass.
  • Findings suggest aldosterone's role in hypertension pathophysiology may differ across ethnic groups and be influenced by obesity.

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...